Current Issue December 2011, Vol. 14, No. 6

Issue Highlights

  • Slipping and sliding: Frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance
    December 2011(Vol. 14 | No. 6 | Pages 251-259)

    Anthony Griffiths

  • Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer
    December 2011(Vol. 14 | No. 6 | Pages 260-279)

    Ranee Mehra, Ilya G. Serebriiskii, Roland L. Dunbrack, Matthew K. Robinson, Barbara Burtness, Erica A. Golemis

  • Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
    December 2011(Vol. 14 | No. 6 | Pages 280-296)

    Francesco Crea, Stefania Nobili, Elisa Paolicchi, Gabriele Perrone, Cristina Napoli, Ida Landini, Romano Danesi, Enrico Mini

  • A framework for global surveillance of antibiotic resistance
    April 2011 (Vol. 14 | No. 2 | Pages 79-87)

    Hajo Grundmann, Keith P. Klugman, Timothy Walsh, Pilar Ramon-Pardo, Betuel Sigauque, Wasif Khan, Ramanan Laxminarayan, Andreas Heddini, John Stelling

  • Fighting bacterial infections—Future treatment options
    April 2011 (Vol. 14 | No. 2 | Pages 125-139)

    Jenny Fernebro

  • New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
    February 2011 (Vol. 14 | No. 1 | Pages 52-66)

    Aviad Hoffman, Alexander J. Lazar, Raphael E. Pollock, Dina Lev

  • Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now
    April 2011 (Vol. 14 | No. 2 | Pages 118-124)

    Laura Freire-Moran, Bo Aronsson, Chris Manz, Inge C. Gyssens, Anthony D. So, Dominique L. Monnet, Otto Cars, the ECDC-EMA Working Group

  • Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
    February 2011 (Vol. 14 | No. 1 | Pages 35-44)

    Yolanda Olmos, Jan J. Brosens, Eric W.-F. Lam

On the Cover


Cover Image

Journal Ranking

Impact Factor

Ranked 5th out of 249 journals in the ISI PHARMACOLOGY & PHARMACY category!
Journal Citation Reports, Science Edition 2011, © ThomsonReuters.

Publishing Information

Drug Resistance Updates is published by Elsevier.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Drug Resistance Updates

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews and commentaries on important developments in drug resistance in infectious disease and cancer. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, oncology and clinical medicine.

Online Poll

Which of the following journal services do you use?

Articles-in-Press section
Email alerts for new issues
Email alerts for citations of a specific article
Saved searches and/or search alerts
Drug information links from within articles

Journal Access

Full-text articles are available from 1998 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers.

Activate Online Access